NutriBand (NTRB) Retained Earnings (2016 - 2026)
NutriBand (NTRB) posted Retained Earnings of $54.0 million for Q2 2026, up 17762009.54% sequentially from -$304.0 in Q1 2026, and up 17762009.54% YoY from N/an in Q2 2025.
NutriBand (NTRB) Retained Earnings (2016 - 2026) Analysis & Trends
NutriBand has reported Retained Earnings for 11 years, with the latest figure at $54.0 million in Q2 2026.
- Quarterly Retained Earnings rose 17762009.54% year-over-year to $54.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $54.0 million (up 17762009.54% YoY) and the FY2026 annual result came in at -$304.0, changed 0.0% from the prior year.
- Retained Earnings rose to $54.0 million in Q2 2026 per NTRB's latest filing, from -$304.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $54.0 million in Q2 2026 and troughed at -$41.9 million in Q3 2025.
- A 5-year average of $2.0 million and a median of -$304.0 in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings sank 10389229.28% in 2024, then surged 17762009.54% in 2026.
- Over 5 years, Retained Earnings stood at -$304.0 in 2022, then plunged by 8585114.8% to -$26.1 million in 2023, then jumped by 100.0% to -$304.0 in 2024, then surged by 17547847.37% to $53.3 million in 2025, then increased by 1.22% to $54.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $54.0 million, -$304.0, and $53.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 54.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 54.00 Mn |
| Jan 31, 2026 | -304.00 |
| Oct 31, 2025 | 53.35 Mn |
| Jul 31, 2025 | -41.85 Mn |
| Apr 30, 2025 | -304.00 |
| Jan 31, 2025 | -304.00 |
| Oct 31, 2024 | -304.00 |
| Jul 31, 2024 | -31.58 Mn |
| Apr 30, 2024 | 43.26 Mn |
| Jan 31, 2024 | -27.98 Mn |
| Oct 31, 2023 | -26.10 Mn |
| Jul 31, 2023 | -304.00 |
| Apr 30, 2023 | -304.00 |
| Jan 31, 2023 | -304.00 |
| Oct 31, 2022 | -304.00 |
| Jul 31, 2022 | 30.26 Mn |
| Apr 30, 2022 | -304.00 |
| Jan 31, 2022 | -18.01 Mn |
| Oct 31, 2021 | 28.49 Mn |
| Jul 31, 2021 | 19.98 Mn |